湯寧信
醫學院(FMD)
ORCID: 0000-0001-6717-5444
ResearcherID: AAD-9404-2019; P-5365-2015
成果: 787 件 | 合作者:4060
WOS核心合集引用:18041 | H Index:63 | WOS收錄:617
CNKI收錄:15 | SCOPUS收錄:505
論文: 787
1.An up-to-date review of emerging biologic therapies for hypercholesterolemia
Tomlinson, B
EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2025, Volume 25, Issue 1, Pages 69-78
收錄情况: WOS SCOPUS
WOS核心合集引用: 2 2024影響因子: 4.0
2.Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia
Tomlinson, B, Chan, More...
EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2025, Volume 26, Issue 3, Pages 279-289
收錄情况: WOS SCOPUS
WOS核心合集引用: 1 2024影響因子: 2.7
Wang, YF, Wang, XY, More...
ADVANCED SCIENCE[2198-3844], Published 2025, Volume 12, Issue 12,
收錄情况: WOS SCOPUS
WOS核心合集引用: 5 2024影響因子: 14.1
Elshorbagy, A, Valle More...
EUROPEAN HEART JOURNAL[0195-668X], Published 2025, Volume 46, Issue 12, Pages 1127-1140
收錄情况: WOS SCOPUS
WOS核心合集引用: 7 2024影響因子: 35.6
Tomlinson, B, Lao, U More...
ATHEROSCLEROSIS[0021-9150], Published 2025, Volume 407,
收錄情况: WOS
WOS核心合集引用: 0 2024影響因子: 5.7
Zeng, WW, Luo, YN, O More...
FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2025, Volume 16,
收錄情况: WOS SCOPUS
WOS核心合集引用: 1 2024影響因子: 4.8
7.Statin-Related Transaminitis-Is It Necessary to Stop Statins?
Tomlinson, B, Zeng, More...
CARDIOVASCULAR DRUGS AND THERAPY[0920-3206], Published 2025,
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2024影響因子: 3.1
8.Antibody-Based Therapeutics for Hypercholesterolemia
Tomlinson, B, Chan, More...
BIOLOGICS-TARGETS & THERAPY[1177-5475], Published 2025, Volume 19, Pages 631-649
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2024影響因子: 3.4
9.Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors
Tomlinson, Brian, Wu More...
Journal of Lipid and Atherosclerosis[2287-2892], Published 2024, Volume 13, Issue 1, Pages 2-20
收錄情况: SCOPUS
本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器
Copyright © 2018 澳門科技大學學者庫